Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIND-CKD phase 3 trial of finerenone in non-diabetic chronic kidney disease
MOH_2021-11-22_010305Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic kidney disease (CKD) comparing Kerendia plus standard therapy with Placebo plus standard therapy (2 arms). Started Nov 2021; status: completed.
02
Drugs
finerenone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on MOH_2021-11-22_010305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-11-22_010305.